Carregant...
Targeted Therapeutic Strategies for the Management of Renal Cell Carcinoma
Agents targeting the VEGF and mTOR pathways remain the mainstay in the management of metastatic RCC. Understanding the importance of the VHL/HIF pathway in clear cell RCC has hitherto guided targeted therapy options in this disease, but other potential targets are beginning to emerge. Ongoing and fu...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3471654/ https://ncbi.nlm.nih.gov/pubmed/22343386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e328351c646 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|